| Product Code: ETC7538921 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India car-t cell therapy treatment market import shipment experienced a negative CAGR from 2020 to 2024. The growth rate between 2023 and 2024 saw a significant decline. The market showed a clear trend of slowing down, indicating a challenging period for imports in this sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India CAR-T Cell Therapy Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 India CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 India CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 India CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 India CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 India CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 India CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in India |
4.2.2 Increasing investment in healthcare infrastructure |
4.2.3 Rising awareness about the benefits of CAR-T cell therapy |
4.2.4 Favorable government initiatives and policies to support advanced medical treatments |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy |
4.3.2 Limited expertise and infrastructure for CAR-T cell therapy in India |
4.3.3 Regulatory challenges and approval process for advanced therapies |
5 India CAR-T Cell Therapy Treatment Market Trends |
6 India CAR-T Cell Therapy Treatment Market, By Types |
6.1 India CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 India CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 India CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 India CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 India CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 India CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 India CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 India CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 India CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 India CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Average waiting time for CAR-T cell therapy treatment |
8.2 Number of clinical trials and research studies related to CAR-T cell therapy in India |
8.3 Patient satisfaction and quality of life improvement post CAR-T cell therapy treatment |
9 India CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 India CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 India CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 India CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 India CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 India CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 India CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 India CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here